WB
H M R
Endogenous
88
Rabbit IgG
#Q99567
4927
Product Information
Product Usage Information
Application | Dilution |
---|---|
Western Blotting | 1:1000 |
Storage
Specificity / Sensitivity
Species Reactivity:
Human, Mouse, Rat
Species predicted to react based on 100% sequence homology
The antigen sequence used to produce this antibody shares
100% sequence homology with the species listed here, but
reactivity has not been tested or confirmed to work by CST.
Use of this product with these species is not covered under
our
Product Performance Guarantee.
Hamster, Bovine, Dog
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly676 of human NUP88 protein.
Background
The nuclear pore complex (NPC) is a multi-subunit protein channel that spans the nuclear envelope and is responsible for the nucleocytoplasmic trafficking of RNA, proteins, and ribonucleoproteins (1). The 88 kDa nucleoporin protein (NUP88) is located on the cytoplasmic side of the NPC and found to be a part of a subcomplex with the NUP214 NPC subunit (1-3). This NUP88/NUP214 subcomplex interacts with CRM-1/exportin-1 to play an important role in the export of proteins, including the 60S ribosomal particle from the nucleus (4,5). Research studies demonstrate elevated expression and cytoplasmic accumulation of NUP88, visible as granular dots, in ovarian, prostate, and breast cancers (6-9). Increased NUP88 levels correlate with higher tumor grade, suggesting that NUP88 may be a putative tumor marker (1,7).
- Xu, S. and Powers, M.A. (2009) Semin Cell Dev Biol 20, 620-30.
- Bastos, R. et al. (1997) J Cell Biol 137, 989-1000.
- Fornerod, M. et al. (1997) EMBO J 16, 807-16.
- Roth, P. et al. (2003) J Cell Biol 163, 701-6.
- Bernad, R. et al. (2006) J Biol Chem 281, 19378-86.
- Martínez, N. et al. (1999) Cancer Res 59, 5408-11.
- Siddiqui, N. and Borden, K.L. (2012) Wiley Interdiscip Rev RNA 3, 13-25.
- Gould, V.E. et al. (2002) Hum Pathol 33, 536-44.
- Gould, V.E. et al. (2000) Am J Pathol 157, 1605-13.
Species Reactivity
Species reactivity is determined by testing in at least one approved application (e.g., western blot).
Western Blot Buffer
IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v BSA, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.
Applications Key
WB: Western Blotting
Cross-Reactivity Key
H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected
Trademarks and Patents
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.